SecBot SecBot
6-K ·Filed Apr 8, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001575872-26-000236
Notable filing: 6-K
Actionable Insight • Neutral

No material impact on valuation or operations is expected. Traders should monitor for any strategic shift implications, but this appears to be a minor portfolio rationalization.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$13.24
T+0 close · Apr 8, 2026 · via day close
Latest settled
+8.61%
T+60 · $14.38
Vs SPY
−1.85%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 8 $13.24entry
  2. T+1 · 7mo ago +0.15%α −0.42% · $13.26
  3. T+5 · 7mo ago −2.27%α −5.78% · $12.94
  4. T+20 · 7mo ago +0.15%α −8.39% · $13.26
  5. T+60 · 4mo ago +8.61%α −1.85% · $14.38
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's Laboratories announced the sale of its wholly owned subsidiary, Svaas Wellness Limited, to Enspirit Technology Services Private Limited for INR 2.23 crore. The transaction, completed on April 7, 2026, results in Svaas Wellness no longer being a subsidiary of the company. The subsidiary contributed approximately 0.09% of Dr. Reddy's consolidated turnover in FY2025.

Key Facts

  • Dr. Reddy's Laboratories sold 100% of its stake in Svaas Wellness Limited on April 7, 2026.
  • The buyer, Enspirit Technology Services Private Limited, is not a related party or part of the promoter group.
  • Sale consideration was INR 2.23 crore (approximately $268,000 USD).
  • Svaas Wellness contributed ~0.09% of Dr. Reddy's consolidated revenue in FY2025 (Rs. 28.5 crore).
  • The transaction does not constitute a related-party deal and was completed outside a scheme of arrangement.

Financial Impact

Minimal financial impact; Svaas Wellness represented only 0.09% of consolidated turnover. Proceeds from the sale are negligible relative to Dr. Reddy's $10.8B market cap.

revenuesubsidiary ownership

Risk Factors

  • Potential reputational risk if Svaas Wellness was a growth initiative now being divested.
  • Limited financial risk given the immaterial size of the subsidiary.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000236
Document: 0001575872-26-000236-index.html0001575872-26-000236
Document: 0001575872-26-000236.txt0001575872-26-000236

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 8, 2026